Comparative Benchmarking
In the context of the broader market, TLSI competes directly with industry leaders such as AVR and CV. With a market capitalization of $231.83M, it holds a significant position in the sector. When comparing efficiency, TLSI's gross margin of N/A stands against AVR's 71.33% and CV's 54.10%. Such benchmarking helps identify whether TriSalus Life Sciences Inc is trading at a premium or discount relative to its financial performance.
